Brandon Imber, MD
Enriched profileAssistant Attending Radiation Oncologist · Memorial Sloan Kettering Cancer Center
Brandon Imber is Assistant Attending Radiation Oncologist at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 319 publications with 2,340 citations (h-index 27); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 25 Oct 2026
Overview
Updated 28 Oct 2026
Brandon Imber, M.D., is Assistant Attending Radiation Oncologist at Memorial Sloan Kettering Cancer Center. The public record shows 319 publications with 2,340 citations (h-index 27), centered on Lymphoma Diagnosis and Treatment, Brain Metastases and Treatment, Glioma Diagnosis and Treatment. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 4 companies.
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Lymphoma Diagnosis and Treatment
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 32 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 48.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- A Study of 177Lu-PSMA-617 in People With Gliomas
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
Sponsor: Memorial Sloan Kettering Cancer Center
Industry payments
Updated 28 Oct 2026
4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GT Medical Technologies, IncProgram year202520 payments$24,159openpaymentsdata.cms.gov ↗
- Telix PharmaceuticalsProgram year20251 payment
- GT Medical Technologies, IncProgram year20247 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
63.5%Corticosteroid63.5%Dexamethasone100%Part D≥40 patientsNervous system
18.8%Benzodiazepine18.8%Lorazepam100%Part D≥17 patientsMetabolism & gastrointestinal
17.7%Proton pump inhibitor17.7%Pantoprazole Sodium100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 28 Oct 2026
90 congress contributions (2014–2026) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Abstract 2116: Genomic landscape of 1007 pan-cancer brain metastases.
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Linac-based stereotactic radiosurgery for brain metastases: Survival and salvage treatment in a contemporary cohort of 3893 patients.
Neuro-oncology advances
Article2026 - Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma.
Blood cancer journal
Letter2026 - Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.
Journal of clinical oncology
Review2026
Most-cited works
by citation count (OpenAlex)- 01Global and regional functional connectivity maps of neural oscillations in focal epilepsyArticle236 citations2015
- 02
- 03Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal CarcinomaArticle108 citations2024
- 04Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaArticle102 citations2022
- 05
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 28 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/brandon-imber-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
mskcc.org/cancer-care/doctors/brandon-imber
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Other
synapse.mskcc.org/synapse/people/17876
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →synapse.mskcc.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of California, San Francisco School of Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - MA
Chemical Biology, Harvard University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- Member
Lymphoma Disease Management Team and MSK Brain Metastasis Center
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center
Seth Steinberg, PhD
National Cancer Institute (NCI)
Gilles Salles
Memorial Sloan Kettering Cancer Center
Thomas Witzig, MD
Mayo Clinic
Wyndham Wilson, MD
National Cancer Institute (NCI)